Prof. Jacob M. Rowe is a Senior Advisor to the Company.He
is Chief of the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center
, Haifa, and former Director of Clinical Services in the Hematology Unit at the University of Rochester Medical Center, NY
...Pluristem Life Systems, Inc, a biotechnology company focusing on proprietary technology to expand stem cells for treatment of genetic, metabolic and blood diseases such as leukemia, lymphoma, sickle cell anemia and immunodeficiencies, today announced that Prof. Jacob Rowe, F.A.C.P. has been appointed Chairman of the Company's Scientific Advisory Board. Prof. Rowe
is presently Chief of the Department of Hematology and Bone Marrow Transplantation at Rambam Medical Center
in Haifa, Israel.Concurrently, he is a Professor of Hemato-Oncology/Bruce Rappaport Faculty of Medicine, at Technion, Israel Institute of Technology in Haifa, Israel; former Adjunct Professor of Medicine at the University of Rochester School of Medicine and Dentistry in Rochester, NY and a Visiting Professor at Northwestern University in Chicago, IL. Among many significant hospital and administrative appointments, Prof. Rowe is a member of the American Society of Hematology (ASH); the Appeals Committee, Hematology for the Israel Ministry of Health; a member of the Hematology Committee, Scientific Council for the Israel Medical Association; a member of the National Oncology Council, Sub-committee on Bone Marrow Transplantation, National Oncology Council, Israel; American Society for Blood and Marrow Transplantation.He has also served as Chairman of the Eastern Cooperative Oncology Group, Leukemia Committee, Bone Marrow Transplantation Core Committee,.Additionally, at Strong Memorial Hospital, Prof. Rowe was a member of the Blood Utilization Committee, House Officer Advisory Committee, Infection Control Committee, Chairman of the Task Force on Implementation of Bone Marrow Transplantation, Director of Clinical Services, Hematology Unit, and Acting Director - Bone Marrow Transplantation Program. Prof. Rowe
has conducted research and clinical trials in blood related malignancies utilizing grants from the National Institute of Health
(NIH) and the National Cancer Institute
(NCI) and holds a number of Faculty appointments at leading teaching medical institutions. He is a graduate of the University College of Medicine in London.Prof. Rowe was granted an B.Sc. in Pharmacology form the University College of London (first class honors) in 1972 and an M.B., B.S. from the University College Hospital Medical School in Clinical Medicine in 1975.
"We are honored that Prof. Rowe
has accepted the appointment as Chairman of Pluristem's Scientific Advisory Board.